Fuxiang Pharmaceutical: Announcement of Board Resolutions
Fuxiang Pharmaceutical: 2024 Semi-Annual Report Summary
Fuxiang Pharmaceutical: Announcement of Supervisory Committee Resolutions
Fuxiang Pharmaceutical: Public Opinion Management System
Fuxiang Pharmaceutical: Special Report on the Occupation of Non-operating Funds and Other Related Capital Transactions for the Semiannual Year of 2024
Fuxiang Pharmaceutical: Announcement on changes in accounting policies
Fuxiang Pharmaceutical: 2024 Semi-Annual Report
Fuxiang Pharmaceutical: Prompt Announcement on the Disclosure of the 2024 Semi-Annual Report
Fuxiang Pharmaceutical: Special Report on the Deposit and Use of Funds Raised in the First Half of 2024
Fuxiang Pharmaceutical: Announcement on the Withdrawal of the Application for the Company to Issue Stock Application Documents to Specific Targets through Simplified Procedures
Jiangxi Fushine Pharmaceutical: Announcement regarding completion of industrial and commercial registration changes and issuance of new business license for subsidiary under control.
Jiangxi Fushine Pharmaceutical: Announcement Regarding Obtaining Government Subsidies
Jiangxi Fushine Pharmaceutical: Announcement Regarding the Completion of Vice General Manager's Shareholding
Jiangxi Fushine Pharmaceutical: Announcement regarding the acquisition of an invention patent certificate by a wholly-owned subsidiary.
Jiangxi Fushine Pharmaceutical: Announcement regarding the overseas listing of the company's invested companies.
Jiangxi Fushine Pharmaceutical: Announcement Regarding the Completion of Vice General Manager's Shareholding
Jiangxi Fushine Pharmaceutical: Announcement on the signing of the “Agreement on Termination of Special Shareholders' Rights”
Jiangxi Fushine Pharmaceutical: Announcement of Resolutions of the 21st Meeting of the Fourth Board of Directors
Jiangxi Fushine Pharmaceutical: Notice on the holding subsidiary completing the registration of industrial and commercial changes and issuing a business license
Jiangxi Fushine Pharmaceutical: Announcement on the progress of the company's provision of guarantees to wholly-owned subsidiaries
No Data